Escherichia coli O157

BMJ 2009; 339 doi: 10.1136/bmj.b4076 (Published 6 October 2009)
Cite this as: BMJ 2009;339:b4076

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Mary Locking, epidemiologist,
  2. John Cowden, consultant epidemiologist, head of gastrointestinal disease and zoonoses programme
  1. 1Health Protection Scotland, Glasgow G3 7LN
  1. mary.locking{at}nhs.net

    Early clinical diagnosis and outbreak identification are essential to prevent serious sequelae and further transmission

    Because the annual incidence rate of Escherichia coli O157 infection in 2008—an unexceptional year—was 2.9 per 100 000 population in the United Kingdom,1 most clinicians will rarely see a case of infection with this or any other serotype of verotoxigenic E coli. It is vital, however, that they—and particularly general practitioners—have a low threshold for suspecting E coli O157 infection, because it can cause serious complications and large outbreaks, as highlighted by recent incidents involving visitors to open farms (www.bmj.com/cgi/content/extract/339/sep15_2/b3795). Such outbreaks also exemplify the difficulties of controlling sources of infection, and the importance of general practitioners in promptly reporting suspected cases, and in preventing both serious sequelae and secondary spread.

    The low infectious dose of E coli O157—probably fewer than 1000 organisms—increases the risk of large outbreaks, and secondary spread, which causes 6-17% of all cases and up to 31% of outbreak cases.2 Bloody diarrhoea occurs in up to 90% of cases, …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL